Ryan Saadi, CEO of Tevogen Bio, emphasizes the pressing need for sustainable healthcare solutions amid soaring U.S. healthcare costs. Tevogen focuses on developing innovative T cell therapies to address critical patient needs, backed by a strong team and intellectual property.